Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2008 1
2013 1
2014 1
2015 1
2016 1
2017 1
2018 3
2019 5
2020 9
2021 5
2022 5
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update.
Eisen A, Somerfield MR, Accordino MK, Blanchette PS, Clemons MJ, Dhesy-Thind S, Dillmon MS, D'Oronzo S, Fletcher GG, Frank ES, Hallmeyer S, Makhoul I, Moy B, Thawer A, Wu JY, Van Poznak CH. Eisen A, et al. Among authors: blanchette ps. J Clin Oncol. 2022 Mar 1;40(7):787-800. doi: 10.1200/JCO.21.02647. Epub 2022 Jan 18. J Clin Oncol. 2022. PMID: 35041467
Impact of 18F-Labeled Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Versus Conventional Staging in Patients With Locally Advanced Breast Cancer.
Dayes IS, Metser U, Hodgson N, Parpia S, Eisen AF, George R, Blanchette P, Cil TD, Arnaout A, Chan A, Levine MN. Dayes IS, et al. Among authors: blanchette p. J Clin Oncol. 2023 Aug 10;41(23):3909-3916. doi: 10.1200/JCO.23.00249. Epub 2023 May 26. J Clin Oncol. 2023. PMID: 37235845 Clinical Trial.
Bone-Targeted Therapy in Early Breast Cancer.
Jerzak KJ, Raphael J, Desautels DN, Blanchette PS, Tyono I, Pritchard KI. Jerzak KJ, et al. Among authors: blanchette ps. Oncology (Williston Park). 2018 Nov 15;32(11):562-9. Oncology (Williston Park). 2018. PMID: 30474104 Free article. Review.
A Multi-Centre Randomized Study Comparing Two Standard of Care Chemotherapy Regimens for Lower-Risk HER2-Positive Breast Cancer.
Fernandes R, Ng TL, Alzahrani MJ, Raphael J, Blanchette P, Black M, Stober C, Pond GR, Cella D, Vandermeer L, Ibrahim M, Clemons M; REaCT Investigators. Fernandes R, et al. Among authors: blanchette p. Curr Oncol. 2023 Aug 4;30(8):7384-7397. doi: 10.3390/curroncol30080535. Curr Oncol. 2023. PMID: 37623016 Free PMC article. Clinical Trial.
40 results